DALLAS, June 11, 2026 (GLOBE NEWSWIRE) — Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
